9-135664247-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001393661.1(LCN9):​c.182G>A​(p.Arg61Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000768 in 1,613,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000077 ( 0 hom. )

Consequence

LCN9
NM_001393661.1 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.693
Variant links:
Genes affected
LCN9 (HGNC:17442): (lipocalin 9) Members of the lipocalin family, such as LCN9, have a common structure consisting of an 8-stranded antiparallel beta-barrel that forms a cup-shaped ligand-binding pocket or calyx. Lipocalins generally bind small hydrophobic ligands and transport them to specific cells (Suzuki et al., 2004 [PubMed 15363845]).[supplied by OMIM, Aug 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.013981223).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LCN9NM_001393661.1 linkuse as main transcriptc.182G>A p.Arg61Gln missense_variant 2/6 ENST00000619315.2 NP_001380590.1
LCN9NR_171893.1 linkuse as main transcriptn.195G>A non_coding_transcript_exon_variant 2/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LCN9ENST00000619315.2 linkuse as main transcriptc.182G>A p.Arg61Gln missense_variant 2/61 NM_001393661.1 ENSP00000482296 P1
LCN9ENST00000430290.6 linkuse as main transcriptn.168G>A non_coding_transcript_exon_variant 2/65
LCN9ENST00000277526.8 linkuse as main transcriptc.182G>A p.Arg61Gln missense_variant, NMD_transcript_variant 2/65 ENSP00000277526

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152064
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000843
AC:
21
AN:
249254
Hom.:
0
AF XY:
0.0000666
AC XY:
9
AN XY:
135228
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000870
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.0000766
AC:
112
AN:
1461580
Hom.:
0
Cov.:
35
AF XY:
0.0000674
AC XY:
49
AN XY:
727102
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000895
Gnomad4 ASJ exome
AF:
0.000804
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000711
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.0000789
AC:
12
AN:
152182
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74400
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000115
Hom.:
0
Bravo
AF:
0.0000718
ExAC
AF:
0.0000414
AC:
5
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 28, 2024The c.182G>A (p.R61Q) alteration is located in exon 2 (coding exon 2) of the LCN9 gene. This alteration results from a G to A substitution at nucleotide position 182, causing the arginine (R) at amino acid position 61 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.2
DANN
Benign
0.91
DEOGEN2
Benign
0.0068
.;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0044
N
LIST_S2
Benign
0.54
T;T
M_CAP
Benign
0.0015
T
MetaRNN
Benign
0.014
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.0
.;L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.22
T
PROVEAN
Benign
0.23
.;N
REVEL
Benign
0.050
Sift
Benign
0.22
.;T
Sift4G
Benign
1.0
T;T
Polyphen
0.67
.;P
Vest4
0.041
MVP
0.014
MPC
0.062
ClinPred
0.023
T
GERP RS
-4.7
Varity_R
0.029
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200277241; hg19: chr9-138556093; COSMIC: COSV52990775; COSMIC: COSV52990775; API